HIGHLIGHTS
- who: Peter Bernhardt et al. from the Department of Radiation Medical Sciences, Institution of Clinical Science, Sahlgrenska Academy, Department of Medical Physics and Bioengineering, Sahlgrenska University Hospital, Laboratory of, Paul Scherrer Institute, Villigen, Switzerland have published the article: Dosimetric Analysis of the Short-Ranged Particle Emitter 161Tb for Radionuclide Therapy of Metastatic Prostate Cancer, in the Journal: Cancers 2021, 13, of /2021/
- what: The aim of this study was to analyze the required absorbed doses to detectable metastases (Dreq ) when using radionuclides with specific membrane antigen (PSMA)-targeting radioligands to achieve a high probability for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.